Systemic absorption of sodium cromoglicate from a new cutaneous emulsion (Altoderm®) in children with atopic dermatitis

European Journal of Dermatology

Volumn 20, Issue 6, 2010, Pages 864-865

  Edwards, Alan Martin ^a   Matthews, Sharon ^a   Arshad, Syed Hasan ^a,b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTODERM; CROMOGLYCATE DISODIUM; UNCLASSIFIED DRUG;

ATOPIC DERMATITIS; DRUG ABSORPTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; URINALYSIS;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CROMOLYN SODIUM; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; EMULSIONS; FEMALE; HUMANS; MALE; SKIN ABSORPTION; TREATMENT OUTCOME;

EID: 78649884202     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.1101     Document Type: Letter

References (5)

1. Stainer R, Matthews S, Arshad SH, et al. Efficacy of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial. Br J Dermatol 2005; 152: 334-41.
2. Moss GF, Jones KM, Ritchie JT, Cox JS. Plasma levels and urinary excretion of disodium cromoglycate after inhalation by human volunteers. Toxicol Appl Pharmacol 1971; 20: 147-56.
3. Ariyanayagam M, Barlow TJG, Graham P, Hall-Smith SP, Harris JM. Topical sodium cromoglycate in the management of atopic eczema - a controlled trial. Br J Dermatol 1985; 112: 343-8. (Pubitemid 15127315)
4. Cox JS, Beach JE, Blair AM, et al. Disodium cromoglycate (Intal). Adv Drug Res 1970; 5: 115-96.
5. Aswania OA, Corlett SA, Chrystyn H. Relative bioavailability of sodium cromoglicate to the lung following inhalation, using urinary excretion. Br J Clin Pharmacol 1999; 47: 613-8. (Pubitemid 29257658)